Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors.

求助中 20 由 Angel 发布于 2026/8/31 17:21:46

DOI:10.1158/1078-0432.CCR-21-3518
作者：Jun Sato,?Toshio Shimizu,?Takafumi Koyama,?Satoru Iwasa,?Akihiko Shimomura,?Shunsuke Kondo,?Shigehisa Kitano,?Kan Yonemori,?Yutaka Fujiwara,?Kenji Tamura,?Takuya Suzuki,?Takao Takase,?Reiko Nagai,?Koh
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1158/1078-0432.CCR-21-3518

American Association for Cancer Research (AACR)

Abstract：Purpose: We report the dose-escalation part of a phase I study of liposomal eribulin (E7389-LF) in Japanese patients with advanced solid tumors and no alternative standard therapy.Patients a

应助信息

等您来应助

上传文件

17小时前

Book学术机器人

2026/8/31 17:21:46 未找到该文献，机器人已退出，请等待人工下载

2026/8/31 17:21:46 Book学术AI机器人收到请求，开始寻找文献

2026/8/31 17:21:46 已向机器人发送请求

17小时前

Angel 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Consensus Guidelines on Diagnostic Brain and Spine Imaging of Spontaneous Intracranial Hypotension.